These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 19651257)
1. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia. Hwang JY; Lee SH; Kim GS; Koh JM; Go MJ; Kim YJ; Kim HC; Kim TH; Hong JM; Park EK; Lee JY; Kim SY Bone; 2009 Dec; 45(6):1098-103. PubMed ID: 19651257 [TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis. Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms and haplotypes of integrinalpha1 (ITGA1) are associated with bone mineral density and fracture risk in postmenopausal Koreans. Lee HJ; Kim SY; Koh JM; Bok J; Kim KJ; Kim KS; Park MH; Shin HD; Park BL; Kim TH; Hong JM; Park EK; Kim DJ; Oh B; Kimm K; Kim GS; Lee JY Bone; 2007 Dec; 41(6):979-86. PubMed ID: 17931993 [TBL] [Abstract][Full Text] [Related]
4. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women. Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902 [TBL] [Abstract][Full Text] [Related]
5. Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from Scotland. Giraudeau FS; McGinnis RE; Gray IC; O'Brien EJ; Doncaster KE; Spurr NK; Ralston SH; Reid DM; Wood J J Bone Miner Res; 2004 Jan; 19(1):31-41. PubMed ID: 14753734 [TBL] [Abstract][Full Text] [Related]
6. The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women. Feldman K; Szappanos A; Butz H; Grolmusz V; Majnik J; Likó I; Kriszt B; Lakatos P; Tóth M; Rácz K; Patócs A Steroids; 2012 Nov; 77(13):1345-51. PubMed ID: 22986073 [TBL] [Abstract][Full Text] [Related]
7. Association of IL-15 polymorphisms with bone mineral density in postmenopausal Korean women. Koh JM; Oh B; Ha MH; Cho KW; Lee JY; Park BL; Shin HD; Bae MA; Kim HJ; Hong JM; Kim TH; Shin HI; Lee SH; Kim GS; Kim SY; Park EK Calcif Tissue Int; 2009 Nov; 85(5):369-78. PubMed ID: 19756346 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the CLCN7 gene are associated with BMD in women. Pettersson U; Albagha OM; Mirolo M; Taranta A; Frattini A; McGuigan FE; Vezzoni P; Teti A; van Hul W; Reid DM; Villa A; Ralston SH J Bone Miner Res; 2005 Nov; 20(11):1960-7. PubMed ID: 16234969 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in 11β-hydroxysteroid dehydrogenase type 1 correlate with the postdexamethasone cortisol levels and bone mineral density in patients evaluated for osteoporosis. Siggelkow H; Etmanski M; Bozkurt S; Groβ P; Koepp R; Brockmöller J; Tzvetkov MV J Clin Endocrinol Metab; 2014 Feb; 99(2):E293-302. PubMed ID: 24285685 [TBL] [Abstract][Full Text] [Related]
11. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Dick IM; Devine A; Prince RL Am J Physiol Endocrinol Metab; 2005 May; 288(5):E989-95. PubMed ID: 15613678 [TBL] [Abstract][Full Text] [Related]
12. Haplotypes of promoter and intron 1 polymorphisms in the COLIA1 gene are associated with increased risk of osteoporosis. Husted LB; Harsløf T; Gonzalez-Bofill N; Schmitz A; Carstens M; Stenkjaer L; Langdahl BL Calcif Tissue Int; 2009 Feb; 84(2):85-96. PubMed ID: 19082910 [TBL] [Abstract][Full Text] [Related]
13. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. Rojano-Mejía D; Coral-Vázquez RM; Espinosa LC; Romero-Hidalgo S; López-Medina G; García Mdel C; Coronel A; Ibarra R; Canto P Maturitas; 2012 Jan; 71(1):49-54. PubMed ID: 22079369 [TBL] [Abstract][Full Text] [Related]
14. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk. Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597 [TBL] [Abstract][Full Text] [Related]
15. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women. Koh JM; Oh B; Lee JY; Lee JK; Kimm K; Park BL; Shin HD; Lee IK; Kim HJ; Hong JM; Kim TH; Kim GS; Kim SY; Park EK J Bone Miner Res; 2007 Nov; 22(11):1752-8. PubMed ID: 17620055 [TBL] [Abstract][Full Text] [Related]
16. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. Vidal C; Brincat M; Xuereb Anastasi A Maturitas; 2006 Mar; 53(4):386-95. PubMed ID: 16343827 [TBL] [Abstract][Full Text] [Related]
17. Total lymphocyte count and femoral bone mineral density in postmenopausal women. Di Monaco M; Vallero F; Di Monaco R; Mautino F; Cavanna A J Bone Miner Metab; 2004; 22(1):58-63. PubMed ID: 14691689 [TBL] [Abstract][Full Text] [Related]
18. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women. Bustamante M; Nogués X; Agueda L; Jurado S; Wesselius A; Cáceres E; Carreras R; Ciria M; Mellibovsky L; Balcells S; Díez-Pérez A; Grinberg D Calcif Tissue Int; 2007 Oct; 81(4):327-32. PubMed ID: 17878995 [TBL] [Abstract][Full Text] [Related]
19. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287 [TBL] [Abstract][Full Text] [Related]
20. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Langdahl BL; Uitterlinden AG; Ralston SH; Trikalinos TA; Balcells S; Brandi ML; Scollen S; Lips P; Lorenc R; Obermayer-Pietsch B; Reid DM; Armas JB; Arp PP; Bassiti A; Bustamante M; Husted LB; Carey AH; Pérez Cano R; Dobnig H; Dunning AM; Fahrleitner-Pammer A; Falchetti A; Karczmarewicz E; Kruk M; van Leeuwen JP; Masi L; van Meurs JB; Mangion J; McGuigan FE; Mellibovsky L; Mosekilde L; Nogués X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Ioannidis JP; ; ; ; ; ; ; ; Bone; 2008 May; 42(5):969-81. PubMed ID: 18284942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]